Iguratimod ≥98.0% (by HPLC, titration analysis)

Supplier: TCI America
Warning

Synonyms: N-[7-(Methanesulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl]formamide, N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulphonamide, N-(3-Formamido-4-oxo-6-phenoxy-4H-chromen-7-yl)methanesulfonamide, N-[7-(Methanesulphonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl]formamide, N-(7-(Methylsulfonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide, N-(7-(Methylsulphonamido)-4-oxo-6-phenoxy-4H-chromen-3-yl)formamide

I0945-250MG I0945-25MG
TCI0945-250MGEA 478.74 CAD
TCI0945-250MG TCI0945-25MG
Iguratimod ≥98.0% (by HPLC, titration analysis)
Iguratimod
Formula: C₁₇H₁₄N₂O₆S
MW: 374.37 g/mol
MDL Number: MFCD00882374
CAS Number: 123663-49-0

Order Now

Specification Test Results

Appearance White to Almost white powder to crystal
Purity (HPLC) min. 98.0 area%
Purity (Neutralization titration) min. 98.0 %
Melting point 238.0 to 242.0 deg-C


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR